Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,433 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,452 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01917942 | Radiotherapy With Humidification in Head And Neck Cancer(RadioHum) | completed | Phase 3 | 210 | Trans Tasman Radiation Oncology GroupOTHER | 1 | Jul 12, 2017 | clinicaltrials |
| NCT01911598 | A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) | completed | Phase 1 | 24 | Genentech, Inc.INDUSTRY | 2 |
| Jul 6, 2017 |
| clinicaltrials |
| NCT03206242 | Rehabilitation Outcomes in Head and Neck Survivors(HNC) | completed | — | 65 | Chang Gung Memorial HospitalOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01807546 | Oral Rigosertib for Squamous Cell Carcinoma | completed | Phase 2 | 64 | Traws Pharma, Inc.INDUSTRY | 1 | Jun 26, 2017 | clinicaltrials |
| NCT02375451 | Effect of Childhood Radioiodine Therapy on Salivary Function | completed | — | 70 | Boston Children's HospitalOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00471471 | Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | completed | Phase 1 | 22 | Ahmad TarhiniOTHER | 1 | Jun 22, 2017 | clinicaltrials |
| NCT01955239 | Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy(SCS-IMRT) | completed | N/A | 106 | University Medical Center GroningenOTHER | 1 | Jun 22, 2017 | clinicaltrials |
| NCT00626639 | A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy | completed | Phase 1 / Phase 2 | 5 | Swedish Orphan BiovitrumINDUSTRY | 0 | Jun 21, 2017 | clinicaltrials |
| NCT01392222 | Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others | completed | — | 21 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2017 | clinicaltrials |
| NCT00006107 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 1 | 31 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT01528163 | Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck(RACATREX) | completed | Phase 2 | 101 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | Jun 14, 2017 | clinicaltrials |
| NCT01576939 | Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer | completed | N/A | 30 | Stanford UniversityOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT02662608 | Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC) | completed | N/A | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT02442661 | Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer | completed | — | 103 | University of Colorado, DenverOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT00026533 | Thalidomide in Treating Patients With Thyroid Cancer | completed | Phase 2 | — | Kenneth AinOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT01927887 | Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study | completed | N/A | 12 | Massachusetts General HospitalOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT03175939 | Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | completed | Phase 2 | 263 | Sun Yat-sen UniversityOTHER | 0 | Jun 5, 2017 | clinicaltrials |
| NCT00095836 | Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy | completed | Phase 2 | 27 | Massachusetts General HospitalOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00388024 | PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy | completed | — | 19 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT02204631 | 2 Phase Use Of Educational Materials In Head And Neck Cancer Center | completed | N/A | 60 | Massachusetts General HospitalOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT00836992 | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | completed | — | 144 | Mayo ClinicOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT03162042 | Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers(MYOCACH) | completed | — | 60 | University Hospital, Clermont-FerrandOTHER | 1 | May 22, 2017 | clinicaltrials |
| NCT01466257 | Biomarkers in Patients With Head and Neck Cancer | completed | — | 70 | ECOG-ACRIN Cancer Research GroupNETWORK | 0 | May 19, 2017 | clinicaltrials |
| NCT00898911 | Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer | completed | — | 30 | ECOG-ACRIN Cancer Research GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01192750 | Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab | completed | — | 79 | ECOG-ACRIN Cancer Research GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01194635 | Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy | completed | — | 69 | ECOG-ACRIN Cancer Research GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01466244 | Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397 | completed | — | 42 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01487733 | Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301 | completed | — | 155 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT01619618 | Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial | completed | — | 183 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 17, 2017 | clinicaltrials |
| NCT00359645 | Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population | completed | Phase 3 | 1,993 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT01467115 | Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer(DREXNECK) | completed | Phase 2 | 1 | Drexel University College of MedicineOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01535898 | Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers | completed | — | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT01539655 | Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib(Vandetanib) | completed | Phase 1 | 34 | SanofiINDUSTRY | 1 | May 2, 2017 | clinicaltrials |
| NCT02109250 | CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice(CaprelsaReg) | completed | — | 10 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | May 2, 2017 | clinicaltrials |
| NCT00519896 | Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer | completed | Phase 2 | 35 | University of WashingtonOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02103010 | Predictive Modelling for Patient Stratification According to Treatment-related Toxicity and Survival After Chemoradiation for Head and Neck Cancer(PRETOXIS) | completed | — | 45 | University Hospital, GhentOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT02705833 | Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada | completed | — | 591 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 24, 2017 | clinicaltrials |
| NCT00004070 | Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer | completed | Phase 1 / Phase 2 | 7 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT02110082 | Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer | completed | Phase 1 | 66 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 19, 2017 | clinicaltrials |
| NCT00004163 | Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | completed | Phase 2 | 14 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT00095563 | Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Apr 18, 2017 | clinicaltrials |
| NCT00431210 | Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | completed | Phase 1 | 28 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT02069769 | Ensuring Communication in Hospice by Oncology Study (ECHO) | completed | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT00970359 | Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 | completed | N/A | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT00605488 | The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer | completed | N/A | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 10, 2017 | clinicaltrials |
| NCT00970502 | Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 15 | Johnny KaoOTHER | 1 | Apr 10, 2017 | clinicaltrials |
| NCT01240590 | A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2017 | clinicaltrials |
| NCT00533884 | Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic | completed | — | 86 | Vanderbilt University Medical CenterOTHER | 1 | Apr 7, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Jul 12, 2017source: clinicaltrials